Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression

Molecular Neurobiology

Volumn 47, Issue 3, 2013, Pages 946-956

  Yang, Mingchong ^a   Qin, Zhaoyu ^b   Zhu, YanYan ^a   Li, Yun ^c   Qin, Yanjiang ^d   Jing, Yongsheng ^e   Liu, Shilian ^a  

^a SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d SHANDONG UNIVERSITY   (China)

^e JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Cerebrospinal fluid; Experimental allergic encephalomyelitis; Secondary progressive multiple sclerosis; Vitamin D; Vitamin D binding protein

Indexed keywords

ALBUMIN; COLECALCIFEROL; GELSOLIN; VITAMIN D BINDING PROTEIN; BIOLOGICAL MARKER;

ADULT; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GEL ELECTROPHORESIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; UPREGULATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WESTERN BLOTTING; AGED; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; LEWIS RAT; METABOLISM; PATHOLOGY; REPRODUCIBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHOLECALCIFEROL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RATS; RATS, INBRED LEW; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPINAL CORD; UP-REGULATION; VITAMIN D-BINDING PROTEIN;

EID: 84887276187     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8387-1     Document Type: Article

References (45)

1. Rivers TM, Sprunt DH, Berry G.P. (1933) Observations on attempts to produce acute disseminate encephalomyelitis in monkeys. J Exp Med 58(1):39-53
2. Hafler DA (2004) Multiple sclerosis. J Clin Invest 113(6):788-794
3. Koch-Henriksen N., Sørensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9 (5):520-532
4. Miller D, Barkhof F, Montalban X., Thompson A, Filippi M. (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 4(5):281-288
5. Ottervald J, Franzén B, Nilsson K., Andersson LI, Khademi M, Eriksson B et al (2010) Multiple sclerosis: identification and clinical evaluation of novel csf biomarkers. J Proteomics 73 (6):1117-1132
6. Leary SM, Porter B, Thompson A.J. (2005) Multiple sclerosis: diagnosis and the management of acute relapses. Postgrad Med J 81(955):302-308
7. Confavreux C, Vukusic S, Moreau T., Adeleine P. (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343(20):1430-1438
8. Viswanathan S, Unlü M, Minden JS (2006) Two-dimensional difference gel electrophoresis. Nat Protoc 1(3):1351-1358
9. Marouga R, David S, Hawkins E. (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382(3):669-678
10. Disanto G, Ramagopalan SV, Para A.E., Handunnetthi L. (2011) The emerging role of vitamin d binding protein in multiple sclerosis. J Neurol 258(3):353-358
11. Schneider C, Schuetz G, Zollner T.M. (2009) Acute neuroinflammation in lewis rats-a model for acute multiple sclerosis relapses. J Neuroimmunol 213 (1-2):84-90
12. Gomme PT, Bertolini J. (2004) Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 22(7):340-345
13. White P, Cooke N. (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11(8):320-327
14. Jirikowski GF, Kaunzner UW, Dief Ael E, Caldwell J.D. (2009) Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus. Histochem Cell Biol 131(3):365-370
15. Semra YK, Seidi OA, Sharief M.K. (2002) Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 122 (1-2):132-139
16. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek M.J., Willett WC et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62(1):60-65
17. Nordvik I, Myhr KM, Nyland H, Bjerve K.S. (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102(3):143-149
18. McDonald WI, Compston A, Edan G., Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1): 121-127
19. Liu S, Bai S, Qin Z., Yang Y, Cui Y, Qin Y. (2009) Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. J Cell Mol Med 13 (8A):1586-1603
20. Gressner OA, Lahme B, Gressner A.M. (2008) Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through ca(2+)-dependent interaction with the megalin/gp330 receptor. Clin Chim Acta 390 (1-2):28-37
21. Spach KM, Hayes C.E. (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175(6):4119-4126
22. Li Y, Qin Z, Yang M., Qin Y, Lin C, Liu S. (2011) Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients. J Cell Biochem 112(7):1930-1937
23. Karp NA, Lilley K.S. (2005) Maximising sensitivity for detecting changes in protein expression: experimental design using minimal cydyes. Proteomics 5(12):3105-3115
24. Tewari AK, Popova-Butler A, El-Mahdy MA, Zweier J.L. (2011) Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS. Proteomics 11(10):2051-2062
25. Dujmovic I (2011) Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. Mult Scler Int 2011:767083
26. Kułakowska A., Ciccarelli NJ, Wen Q, Mroczko B., Drozdowski W, Szmitkowski M et al (2010) Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol 10:107
27. Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30(6):445-456
28. McLeod JF, Cooke N.E. (1989) The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J Biol Chem 264(36):21760-21769
29. Paul C, Bolton C. (1995) Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int J Immunopharmacol 17(6):497-503
30. Bennett J, Basivireddy J, Kollar A., Biron KE, Reickmann P, Jefferies WA et al (2010) Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model eae. J Neuroimmunol 229 (1-2):180-191
31. Haddad JG, Hu YZ, Kowalski M.A., Laramore C., Ray K, Robzyk P et al (1992) Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (gc-globulin). Biochemistry 31(31):7174-7181
32. Lee WM, Galbraith R.M. (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326(20):1335-1341
33. Haddad JG, Harper KD, Guoth M, Pietra G.G., Sanger J.W. (1990) Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci U S A 87 (4):1381-1385
34. Piquette CA, Robinson-Hill R, Webster R.O. (1994) Human mono-cyte chemotaxis to complement-derived chemotaxins is enhanced by gc-globulin. J Leukoc Biol 55(3):349-354
35. Kew RR, Webster R.O. (1988) Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of c5a and c5a des arg. J Clin Invest 82(1):364-369
36. Gressner O, Meier U, Hillebrandt S., Wasmuth HE, Köhl J, Sauerbruch T et al (2007) Gc-globulin concentrations and c5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor c5. Clin Biochem 40(11):771-775
37. Shah AB, DiMartino SJ, Trujillo G, Kew R.R. (2006) Selective inhibition of the c5a chemotactic cofactor function of the vitamin D binding protein by 1,25(oh)2 vitamin d3. Mol Immunol 43 (8):1109-1115
38. Head JF, Swamy N, Ray R. (2002) Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5 a resolution. Biochemistry 41(29):9015-9020
39. Munger KL, Levin LI, Hollis B.W., Howard NS, Ascherio A. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832-2838
40. Ascherio A, Munger KL, Simon K.C. (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9(6):599-612
41. Nashold FE, Miller DJ, Hayes C.E. (2000) 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 103(2):171-179
42. Nashold FE, Hoag KA, Goverman J, Hayes C.E. (2001) Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 119(1):16-29
43. Hayes CE, Nashold FE, Spach K.M., Pedersen L.B. (2003) The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 49(2):277-300
44. Carpenter TO, Zhang JH, Parra E, Ellis B.K., Simpson C., Lee WM et al (2012) Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. J Bone Miner Res 28(1):213-221
45. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W., Rager H, Virtamo J, Albanes D. (2012) Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 72 (5):1190-1198